The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • Gene obtained from curated document aligns with the Allele Registry but not with ClinVar data
  • No CSPEC computed assertion could be determined for this classification!


Variant: NM_001323289.2(CDKL5):c.863C>G (p.Thr288Arg)

CA412355847

1879751 (ClinVar)

Gene: CDKL5 (HGNC:6792)
Condition: CDKL5 disorder (MONDO:0100039)
Inheritance Mode: X-linked inheritance
UUID: 18e3e3c3-2b62-4a8c-9bb7-eed9a840b51a
Approved on: 2025-10-28
Published on: 2025-12-23

HGVS expressions

NM_001323289.2:c.863C>G
NM_001323289.2(CDKL5):c.863C>G (p.Thr288Arg)
NC_000023.11:g.18598499C>G
CM000685.2:g.18598499C>G
NC_000023.10:g.18616619C>G
CM000685.1:g.18616619C>G
NC_000023.9:g.18526540C>G
NG_008475.1:g.177895C>G
ENST00000623535.2:c.863C>G
ENST00000635828.1:c.863C>G
ENST00000637881.1:c.863C>G
ENST00000674046.1:c.863C>G
ENST00000379989.6:c.863C>G
ENST00000379996.7:c.863C>G
ENST00000463994.4:c.863C>G
ENST00000623535.1:c.863C>G
NM_001037343.1:c.863C>G
NM_003159.2:c.863C>G
NM_001323289.1:c.863C>G
NM_001037343.2:c.863C>G
NM_003159.3:c.863C>G
More

Likely Pathogenic

Met criteria codes 4
PS2 PS4_Supporting PM2_Supporting PP3

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Rett and Angelman-like Disorders Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for CDKL5 Version 5.0.0

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Rett and Angelman-like Disorders VCEP
The p.Thr288Arg variant in CDKL5 has been reported as a de novo occurrence (biological parentage confirmed) in an individual with early onset epilepsy (internal database - CeGaT Center for Human Genetics Tuebingen) (PS2). The p.Thr288Arg variant has been observed in at least 1 other individual with features of CDKL5 disorder (internal database - LabCorp (formerly Invitae)) (PS4_Supporting). The p.Thr288Arg variant in CDKL5 is absent from gnomAD v4.1 (PM2_Supporting). Computational prediction analysis tools suggests a deleterious impact; however, this information does not predict clinical significance on its own (PP3). In summary, the p.Thr288Arg variant in CDKL5 is classified as Likely Pathogenic for CDKL5 disorder based on the ACMG/AMP criteria (PS2, PS4_Supporting, PM2_Supporting, PP3). (CDKL5 Specifications v5.0; curation approved on 10/28/2025)
Met criteria codes
PS2
The p.Thr288Arg variant in CDKL5 has been reported as a de novo occurrence (biological parentage confirmed) in an individual with early onset epilepsy (internal database - CeGaT Center for Human Genetics Tuebingen) (PS2).
PS4_Supporting
The p.Thr288Arg variant has been observed in at least 1 other individual with features of CDKL5 disorder (internal database - LabCorp (formerly Invitae)) (PS4_Supporting).
PM2_Supporting
The p.Thr288Arg variant in CDKL5 is absent from gnomAD v4.1 (PM2_Supporting).
PP3
Computational prediction analysis tools suggests a deleterious impact; however, this information does not predict clinical significance on its own (PP3).
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
ClinGen Terms of Use.
¤ Powered by BCM's Genboree.